Treatment of Hemodialysis-Associated Adynamic Bone Disease with Teriparatide (PTH1–34): A Pilot Study

Publisher： Karger

E-ISSN： 1423-0143|33|3|221-226

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.33, Iss.3, 2010-06, pp. : 221-226

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vitamin D3 Withdrawal in Hemodialysis Patients with Adynamic Bone Disease

By  

Nephron, Vol. 80, Iss. 1, 1998-09 ,pp. : 89-89

Karger

Access to resources Recommend Favorite

Measurement of PTH Fragments for Assessment of Renal Bone Disease in Hemodialysis Patients

By  

Kidney and Blood Pressure Research, Vol. 29, Iss. 3, 2006-10 ,pp. : 175-181

Karger

Access to resources Recommend Favorite

Causes and Consequences of Adynamic Bone Disease

By  

Nephron, Vol. 88, Iss. 2, 2001-05 ,pp. : 97-106

Karger

Access to resources Recommend Favorite

Bisphosphonate Use in Chronic Kidney Disease: Association with Adynamic Bone Disease in a Bone Histology Series

By  

Blood Purification, Vol. 29, Iss. 3, 2010-01 ,pp. : 293-299

Karger

Access to resources Recommend Favorite

Comparison of Dialysis and Clinical Characteristics of Patients with Frequent and Occasional Hemodialysis-Associated Hypotension

By  

Kidney and Blood Pressure Research, Vol. 25, Iss. 2, 2002-07 ,pp. : 97-102

Karger

Access to resources Recommend Favorite